Jaguar Gene Therapy was founded with the mission to accelerate breakthroughs in gene therapy for patients suffering from severe genetic diseases. The company envisions a world where patients and families no longer have to hear that there are no treatment options available. Jaguar Gene Therapy focuses on developing innovative gene therapies that address the root causes of these conditions, aiming to transform the lives of those affected.

Notable affiliated people include industry experts and leaders in gene therapy and biotechnology. The company has garnered significant attention and investment from leading venture capital firms and biotech investors. Key achievements include advancing multiple gene therapy programs into clinical development, demonstrating promising preclinical results, and establishing strategic partnerships with research institutions. Jaguar Gene Therapy's impact lies in its potential to provide life-changing treatments for patients with previously untreatable genetic disorders.